Lv4
470 积分 2025-05-15 加入
CD58 Aberrations Limit Durable Responses to CD19 CAR in Large B Cell Lymphoma Patients Treated with Axicabtagene Ciloleucel but Can be Overcome through Novel CAR Engineering
6小时前
已完结
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
21天前
已完结
CD58/CD2 Is the Primary Costimulatory Pathway in Human CD28−CD8+ T Cells
21天前
已完结
Molecular portraits of human breast tumours
21天前
已完结
Ligand-induced Conformational Change Within the CD2 Ectodomain Accompanies Receptor Clustering: Implication for Molecular Lattice Formation
22天前
已完结
Abstract 3501: A novel CD2-targeted costimulatory bispecific antibody platform for enhancing CD3 T cell engager-based cancer immunotherapy
1个月前
已关闭
Selection of Non-aggregating VH Binders from Synthetic VH Phage-Display Libraries
1个月前
已完结
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models
1个月前
已完结
Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies
1个月前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
1个月前
已完结
皖公网安备34019202002308
